Literature DB >> 16022175

A practical comparison of group-sequential and adaptive designs.

Patrick J Kelly1, M Roshini Sooriyarachchi, Nigel Stallard, Susan Todd.   

Abstract

Sequential methods provide a formal framework by which clinical trial data can be monitored as they accumulate. The results from interim analyses can be used either to modify the design of the remainder of the trial or to stop the trial as soon as sufficient evidence of either the presence or absence of a treatment effect is available. The circumstances under which the trial will be stopped with a claim of superiority for the experimental treatment, must, however, be determined in advance so as to control the overall type I error rate. One approach to calculating the stopping rule is the group-sequential method. A relatively recent alternative to group-sequential approaches is the adaptive design method. This latter approach provides considerable flexibility in changes to the design of a clinical trial at an interim point. However, a criticism is that the method by which evidence from different parts of the trial is combined means that a final comparison of treatments is not based on a sufficient statistic for the treatment difference, suggesting that the method may lack power. The aim of this paper is to compare two adaptive design approaches with the group-sequential approach. We first compare the form of the stopping boundaries obtained using the different methods. We then focus on a comparison of the power of the different trials when they are designed so as to be as similar as possible. We conclude that all methods acceptably control type I error rate and power when the sample size is modified based on a variance estimate, provided no interim analysis is so small that the asymptotic properties of the test statistic no longer hold. In the latter case, the group-sequential approach is to be preferred. Provided that asymptotic assumptions hold, the adaptive design approaches control the type I error rate even if the sample size is adjusted on the basis of an estimate of the treatment effect, showing that the adaptive designs allow more modifications than the group-sequential method.

Mesh:

Year:  2005        PMID: 16022175     DOI: 10.1081/BIP-200062859

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  4 in total

1.  CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.

Authors:  David Moher; Sally Hopewell; Kenneth F Schulz; Victor Montori; Peter C Gøtzsche; P J Devereaux; Diana Elbourne; Matthias Egger; Douglas G Altman
Journal:  BMJ       Date:  2010-03-23

Review 2.  Adaptive trial designs for spinal cord injury clinical trials directed to the central nervous system.

Authors:  James D Guest; John D Steeves; M J Mulcahey; Linda A T Jones; Frank Rockhold; Rϋediger Rupp; John L K Kramer; Steven Kirshblum; Andrew Blight; Daniel Lammertse
Journal:  Spinal Cord       Date:  2020-09-16       Impact factor: 2.772

3.  Designing and conducting proof-of-concept chronic pain analgesic clinical trials.

Authors:  Claudia M Campbell; Ian Gilron; Tina Doshi; Srinivasa Raja
Journal:  Pain Rep       Date:  2019-02-26

4.  Interim data monitoring in cluster randomised trials: Practical issues and a case study.

Authors:  K Hemming; J Martin; I Gallos; A Coomarasamy; L Middleton
Journal:  Clin Trials       Date:  2021-06-22       Impact factor: 2.486

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.